155 related articles for article (PubMed ID: 6124267)
1. Nadolol in thyrotoxicosis.
Peden NR; Isles TE; Stevenson IH; Crooks J
Br J Clin Pharmacol; 1982 Jun; 13(6):835-40. PubMed ID: 6124267
[TBL] [Abstract][Full Text] [Related]
2. A comparison of propranolol and nadolol pharmacokinetics and clinical effects in thyrotoxicosis.
Wilkinson R; Burr WA
Am Heart J; 1984 Oct; 108(4 Pt 2):1160-7. PubMed ID: 6148879
[TBL] [Abstract][Full Text] [Related]
3. [The effect of the beta-blockers nadolol and metipranolol in patients with thyrotoxicosis].
Vavrejnová V; Felt V; Nedvídková J
Cas Lek Cesk; 1985 Oct; 124(43):1320-3. PubMed ID: 2867827
[No Abstract] [Full Text] [Related]
4. Comparison between atenolol and nadolol in essential hypertension at rest and on exercise.
Wilcox RG; Hampton JR
Br J Clin Pharmacol; 1982 Jun; 13(6):841-6. PubMed ID: 6124268
[TBL] [Abstract][Full Text] [Related]
5. Nadolol and potassium iodide in combination in the surgical treatment of thyrotoxicosis.
Peden NR; Gunn A; Browning MC; Crooks J; Forrest AL; Hamilton WF; Isles TE
Br J Surg; 1982 Nov; 69(11):638-40. PubMed ID: 6127134
[TBL] [Abstract][Full Text] [Related]
6. [Nadolol-induced adrenergic beta-block in the treatment of thyrotoxicosis (author's transl)].
Felt V; Nedvídková J
Cas Lek Cesk; 1982 Mar; 121(9):266-8. PubMed ID: 6121628
[No Abstract] [Full Text] [Related]
7. Effects of nadolol beta-blockade on blood pressure in hypertension.
Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA
Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
[TBL] [Abstract][Full Text] [Related]
8. Prolonged effect of nadolol on heart rate in hyperthyroidism.
Adam RD; Parekh P; Harrower AD
Curr Med Res Opin; 1981; 7(4):212-4. PubMed ID: 6112117
[TBL] [Abstract][Full Text] [Related]
9. [Lowering the heart rate in tachycardiac atrial fibrillation by beta receptor blockade].
Horn HG; Neuss H; Schlepper M; Mitrovic V; Stämmler G
Med Klin; 1980 Sep; 75(20):721-5. PubMed ID: 6106885
[TBL] [Abstract][Full Text] [Related]
10. Beta adrenoceptor blockade and responses of serum lipids to a meal and to exercise.
Peden NR; Dow RJ; Isles TE; Martin BT
Br Med J (Clin Res Ed); 1984 Jun; 288(6433):1788-90. PubMed ID: 6145480
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenergic blockade by nadolol in control of ventricular tachyarrhythmias.
Nademanee K; Schleman MM; Singh BN; Morganroth J; Reid PR; Stritar JA
Am Heart J; 1984 Oct; 108(4 Pt 2):1109-15. PubMed ID: 6207720
[TBL] [Abstract][Full Text] [Related]
12. A study of nadolol to determine its effect on ambulatory blood pressure over 24 hours, and during exercise testing.
Hornung RS; Gould BA; Kieso H; Raftery EB
Br J Clin Pharmacol; 1982 Jul; 14(1):83-8. PubMed ID: 6125200
[TBL] [Abstract][Full Text] [Related]
13. Tremor: an alternative approach for investigating adrenergic mechanisms in thyrotoxicosis?
Abila B; Lazarus JH; Kingswood JC; Marshall RW; Wilson JF; Richens A
Clin Sci (Lond); 1985 Oct; 69(4):459-63. PubMed ID: 2864158
[TBL] [Abstract][Full Text] [Related]
14. Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin.
DiBianco R; Morganroth J; Freitag JA; Ronan JA; Lindgren KM; Donohue DJ; Larca LJ; Chadda KD; Olukotun AY
Am Heart J; 1984 Oct; 108(4 Pt 2):1121-7. PubMed ID: 6148872
[TBL] [Abstract][Full Text] [Related]
15. Interactions of beta-adrenoceptor antagonists and thyroid hormones in the control of heart rate in the dog.
Allely MC; Ungar A
Br J Pharmacol; 1985 Oct; 86(2):393-8. PubMed ID: 2864972
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.
O'Callaghan WG; Laher MS; McGarry K; O'Brien E; O'Malley K
Br J Clin Pharmacol; 1983 Oct; 16(4):417-21. PubMed ID: 6138058
[TBL] [Abstract][Full Text] [Related]
17. Nadolol in hypertensive patients maintained on long-term hemodialysis.
Michaels RS; Duchin KL; Akbar S; Meister J; Levin NW
Am Heart J; 1984 Oct; 108(4 Pt 2):1091-4. PubMed ID: 6148869
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biochemical responses to nadolol and clonidine in hyperthyroidism.
Herman VS; Joffe BI; Kalk WJ; Panz V; Wing J; Seftel HC
J Clin Pharmacol; 1989 Dec; 29(12):1117-20. PubMed ID: 2693501
[TBL] [Abstract][Full Text] [Related]
19. Long-term renal hemodynamic effects of nadolol in patients with essential hypertension.
Frohlich ED; Messerli FH; Deslinski GR; Kobrin I
Am Heart J; 1984 Oct; 108(4 Pt 2):1141-3. PubMed ID: 6148875
[TBL] [Abstract][Full Text] [Related]
20. [The effect of the beta-blocker nadolol on the second messenger, serum cyclic adenosine monophosphate, and on blood pressure and heart rate].
Weth G; Schneider J; Rodatz H; Haubitz I
Arzneimittelforschung; 1985; 35(11):1711-3. PubMed ID: 2868733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
